Table of Content

1 Report Overview
1.1 Seasonal Influenza Vaccines Definition
1.2 Market by Type
1.2.1 Global Seasonal Influenza Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Type A (H1N1)
1.2.3 Type A (H3N2)
1.2.4 Type B
1.3 Market Segment by Application
1.3.1 Global Seasonal Influenza Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Pediatrics
1.3.3 Adolescence
1.3.4 Adults
1.3.5 Elderly
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Seasonal Influenza Vaccines Sales
2.1 Global Seasonal Influenza Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global Seasonal Influenza Vaccines Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Seasonal Influenza Vaccines Revenue by Region
2.3.1 Global Seasonal Influenza Vaccines Revenue by Region (2018-2024)
2.3.2 Global Seasonal Influenza Vaccines Revenue by Region (2024-2034)
2.4 Global Seasonal Influenza Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Seasonal Influenza Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Seasonal Influenza Vaccines Sales Quantity by Region
2.6.1 Global Seasonal Influenza Vaccines Sales Quantity by Region (2018-2024)
2.6.2 Global Seasonal Influenza Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Seasonal Influenza Vaccines Sales Quantity by Manufacturers
3.1.1 Global Seasonal Influenza Vaccines Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Seasonal Influenza Vaccines Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccines Sales in 2022
3.2 Global Seasonal Influenza Vaccines Revenue by Manufacturers
3.2.1 Global Seasonal Influenza Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Seasonal Influenza Vaccines Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccines Revenue in 2022
3.3 Global Seasonal Influenza Vaccines Sales Price by Manufacturers
3.4 Global Key Players of Seasonal Influenza Vaccines, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Seasonal Influenza Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Seasonal Influenza Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Seasonal Influenza Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Seasonal Influenza Vaccines Sales Quantity by Type
4.1.1 Global Seasonal Influenza Vaccines Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Seasonal Influenza Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Seasonal Influenza Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global Seasonal Influenza Vaccines Revenue by Type
4.2.1 Global Seasonal Influenza Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Seasonal Influenza Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Seasonal Influenza Vaccines Price by Type
4.3.1 Global Seasonal Influenza Vaccines Price by Type (2018-2024)
4.3.2 Global Seasonal Influenza Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Seasonal Influenza Vaccines Sales Quantity by Application
5.1.1 Global Seasonal Influenza Vaccines Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Seasonal Influenza Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Seasonal Influenza Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global Seasonal Influenza Vaccines Revenue by Application
5.2.1 Global Seasonal Influenza Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Seasonal Influenza Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Seasonal Influenza Vaccines Price by Application
5.3.1 Global Seasonal Influenza Vaccines Price by Application (2018-2024)
5.3.2 Global Seasonal Influenza Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America Seasonal Influenza Vaccines Sales by Company
6.1.1 North America Seasonal Influenza Vaccines Revenue by Company (2018-2024)
6.1.2 North America Seasonal Influenza Vaccines Sales Quantity by Company (2018-2024)
6.2 North America Seasonal Influenza Vaccines Market Size by Type
6.2.1 North America Seasonal Influenza Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America Seasonal Influenza Vaccines Revenue by Type (2018-2034)
6.3 North America Seasonal Influenza Vaccines Market Size by Application
6.3.1 North America Seasonal Influenza Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America Seasonal Influenza Vaccines Revenue by Application (2018-2034)
6.4 North America Seasonal Influenza Vaccines Market Size by Country
6.4.1 North America Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Seasonal Influenza Vaccines Revenue by Country (2018-2034)
6.4.3 North America Seasonal Influenza Vaccines Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Seasonal Influenza Vaccines Sales by Company
7.1.1 Europe Seasonal Influenza Vaccines Sales Quantity by Company (2018-2024)
7.1.2 Europe Seasonal Influenza Vaccines Revenue by Company (2018-2024)
7.2 Europe Seasonal Influenza Vaccines Market Size by Type
7.2.1 Europe Seasonal Influenza Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe Seasonal Influenza Vaccines Revenue by Type (2018-2034)
7.3 Europe Seasonal Influenza Vaccines Market Size by Application
7.3.1 Europe Seasonal Influenza Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe Seasonal Influenza Vaccines Revenue by Application (2018-2034)
7.4 Europe Seasonal Influenza Vaccines Market Size by Country
7.4.1 Europe Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Seasonal Influenza Vaccines Revenue by Country (2018-2034)
7.4.3 Europe Seasonal Influenza Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Seasonal Influenza Vaccines Sales by Company
8.1.1 China Seasonal Influenza Vaccines Sales Quantity by Company (2018-2024)
8.1.2 China Seasonal Influenza Vaccines Revenue by Company (2018-2024)
8.2 China Seasonal Influenza Vaccines Market Size by Type
8.2.1 China Seasonal Influenza Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China Seasonal Influenza Vaccines Revenue by Type (2018-2034)
8.3 China Seasonal Influenza Vaccines Market Size by Application
8.3.1 China Seasonal Influenza Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China Seasonal Influenza Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Seasonal Influenza Vaccines Sales by Company
9.1.1 APAC Seasonal Influenza Vaccines Sales Quantity by Company (2018-2024)
9.1.2 APAC Seasonal Influenza Vaccines Revenue by Company (2018-2024)
9.2 APAC Seasonal Influenza Vaccines Market Size by Type
9.2.1 APAC Seasonal Influenza Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC Seasonal Influenza Vaccines Revenue by Type (2018-2034)
9.3 APAC Seasonal Influenza Vaccines Market Size by Application
9.3.1 APAC Seasonal Influenza Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC Seasonal Influenza Vaccines Revenue by Application (2018-2034)
9.4 APAC Seasonal Influenza Vaccines Market Size by Region
9.4.1 APAC Seasonal Influenza Vaccines Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Seasonal Influenza Vaccines Revenue by Region (2018-2034)
9.4.3 APAC Seasonal Influenza Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Seasonal Influenza Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Seasonal Influenza Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Seasonal Influenza Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 GlaxoSmithKline plc
11.1.1 GlaxoSmithKline plc Company Information
11.1.2 GlaxoSmithKline plc Overview
11.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Products and Services
11.1.5 GlaxoSmithKline plc Seasonal Influenza Vaccines SWOT Analysis
11.1.6 GlaxoSmithKline plc Recent Developments
11.2 Sinovac Biotech Ltd
11.2.1 Sinovac Biotech Ltd Company Information
11.2.2 Sinovac Biotech Ltd Overview
11.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Products and Services
11.2.5 Sinovac Biotech Ltd Seasonal Influenza Vaccines SWOT Analysis
11.2.6 Sinovac Biotech Ltd Recent Developments
11.3 Changsheng Bio-Technology
11.3.1 Changsheng Bio-Technology Company Information
11.3.2 Changsheng Bio-Technology Overview
11.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Products and Services
11.3.5 Changsheng Bio-Technology Seasonal Influenza Vaccines SWOT Analysis
11.3.6 Changsheng Bio-Technology Recent Developments
11.4 Ccbio SA
11.4.1 Ccbio SA Company Information
11.4.2 Ccbio SA Overview
11.4.3 Ccbio SA Seasonal Influenza Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Ccbio SA Seasonal Influenza Vaccines Products and Services
11.4.5 Ccbio SA Seasonal Influenza Vaccines SWOT Analysis
11.4.6 Ccbio SA Recent Developments
11.5 Aleph Biomedical
11.5.1 Aleph Biomedical Company Information
11.5.2 Aleph Biomedical Overview
11.5.3 Aleph Biomedical Seasonal Influenza Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Aleph Biomedical Seasonal Influenza Vaccines Products and Services
11.5.5 Aleph Biomedical Seasonal Influenza Vaccines SWOT Analysis
11.5.6 Aleph Biomedical Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi Overview
11.6.3 Sanofi Seasonal Influenza Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Sanofi Seasonal Influenza Vaccines Products and Services
11.6.5 Sanofi Seasonal Influenza Vaccines SWOT Analysis
11.6.6 Sanofi Recent Developments
11.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
11.7.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
11.7.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Overview
11.7.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Products and Services
11.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines SWOT Analysis
11.7.6 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
11.8 Dalian Hissen Bio-pharm
11.8.1 Dalian Hissen Bio-pharm Company Information
11.8.2 Dalian Hissen Bio-pharm Overview
11.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Products and Services
11.8.5 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines SWOT Analysis
11.8.6 Dalian Hissen Bio-pharm Recent Developments
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Information
11.9.2 Abbott Laboratories Overview
11.9.3 Abbott Laboratories Seasonal Influenza Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Abbott Laboratories Seasonal Influenza Vaccines Products and Services
11.9.5 Abbott Laboratories Seasonal Influenza Vaccines SWOT Analysis
11.9.6 Abbott Laboratories Recent Developments
11.10 Novartis International AG
11.10.1 Novartis International AG Company Information
11.10.2 Novartis International AG Overview
11.10.3 Novartis International AG Seasonal Influenza Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Novartis International AG Seasonal Influenza Vaccines Products and Services
11.10.5 Novartis International AG Seasonal Influenza Vaccines SWOT Analysis
11.10.6 Novartis International AG Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Seasonal Influenza Vaccines Value Chain Analysis
12.2 Seasonal Influenza Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Seasonal Influenza Vaccines Production Mode & Process
12.4 Seasonal Influenza Vaccines Sales and Marketing
12.4.1 Seasonal Influenza Vaccines Sales Channels
12.4.2 Seasonal Influenza Vaccines Distributors
12.5 Seasonal Influenza Vaccines Customers
13 Market Dynamics
13.1 Seasonal Influenza Vaccines Industry Trends
13.2 Seasonal Influenza Vaccines Market Drivers
13.3 Seasonal Influenza Vaccines Market Challenges
13.4 Seasonal Influenza Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Type A (H1N1)
Table 3. Major Manufacturers of Type A (H3N2)
Table 4. Major Manufacturers of Type B
Table 5. Global Seasonal Influenza Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Seasonal Influenza Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Seasonal Influenza Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2018-2024)
Table 9. Global Seasonal Influenza Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2024-2034)
Table 11. Global Seasonal Influenza Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 12. Global Seasonal Influenza Vaccines Sales by Region (2018-2024) & (K Units)
Table 13. Global Seasonal Influenza Vaccines Sales Market Share by Region (2018-2024)
Table 14. Global Seasonal Influenza Vaccines Sales by Region (2024-2034) & (K Units)
Table 15. Global Seasonal Influenza Vaccines Sales Market Share by Region (2024-2034)
Table 16. Global Seasonal Influenza Vaccines Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 17. Global Seasonal Influenza Vaccines Sales Quantity Share by Manufacturers (2018-2024)
Table 18. Global Seasonal Influenza Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Seasonal Influenza Vaccines Revenue Share by Manufacturers (2018-2024)
Table 20. Global Seasonal Influenza Vaccines Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Key Players of Seasonal Influenza Vaccines, Industry Ranking, 2021 VS 2022
Table 22. Global Seasonal Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Seasonal Influenza Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Influenza Vaccines as of 2022)
Table 24. Global Key Manufacturers of Seasonal Influenza Vaccines, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Seasonal Influenza Vaccines, Product Offered and Application
Table 26. Global Key Manufacturers of Seasonal Influenza Vaccines, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Seasonal Influenza Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 29. Global Seasonal Influenza Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 30. Global Seasonal Influenza Vaccines Sales Quantity Share by Type (2018-2024)
Table 31. Global Seasonal Influenza Vaccines Sales Quantity Share by Type (2024-2034)
Table 32. Global Seasonal Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Seasonal Influenza Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Seasonal Influenza Vaccines Revenue Share by Type (2018-2024)
Table 35. Global Seasonal Influenza Vaccines Revenue Share by Type (2024-2034)
Table 36. Seasonal Influenza Vaccines Price by Type (2018-2024) & (USD/Unit)
Table 37. Global Seasonal Influenza Vaccines Price Forecast by Type (2024-2034) & (USD/Unit)
Table 38. Global Seasonal Influenza Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 39. Global Seasonal Influenza Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 40. Global Seasonal Influenza Vaccines Sales Quantity Share by Application (2018-2024)
Table 41. Global Seasonal Influenza Vaccines Sales Quantity Share by Application (2024-2034)
Table 42. Global Seasonal Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Seasonal Influenza Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Seasonal Influenza Vaccines Revenue Share by Application (2018-2024)
Table 45. Global Seasonal Influenza Vaccines Revenue Share by Application (2024-2034)
Table 46. Seasonal Influenza Vaccines Price by Application (2018-2024) & (USD/Unit)
Table 47. Global Seasonal Influenza Vaccines Price Forecast by Application (2024-2034) & (USD/Unit)
Table 48. North America Seasonal Influenza Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 49. North America Seasonal Influenza Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 50. North America Seasonal Influenza Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 51. North America Seasonal Influenza Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 52. North America Seasonal Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 53. North America Seasonal Influenza Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Seasonal Influenza Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 55. North America Seasonal Influenza Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 56. North America Seasonal Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 57. North America Seasonal Influenza Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 59. North America Seasonal Influenza Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 60. North America Seasonal Influenza Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Seasonal Influenza Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 62. North America Seasonal Influenza Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 63. Europe Seasonal Influenza Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 64. Europe Seasonal Influenza Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 65. Europe Seasonal Influenza Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 66. Europe Seasonal Influenza Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 67. Europe Seasonal Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 68. Europe Seasonal Influenza Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Seasonal Influenza Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 70. Europe Seasonal Influenza Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 71. Europe Seasonal Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 72. Europe Seasonal Influenza Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 74. Europe Seasonal Influenza Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 75. Europe Seasonal Influenza Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Seasonal Influenza Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 77. Europe Seasonal Influenza Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 78. China Seasonal Influenza Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 79. China Seasonal Influenza Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 80. China Seasonal Influenza Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 81. China Seasonal Influenza Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 82. China Seasonal Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 83. China Seasonal Influenza Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Seasonal Influenza Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 85. China Seasonal Influenza Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 86. China Seasonal Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 87. China Seasonal Influenza Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Seasonal Influenza Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 89. APAC Seasonal Influenza Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 90. APAC Seasonal Influenza Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 91. APAC Seasonal Influenza Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 92. APAC Seasonal Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 93. APAC Seasonal Influenza Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Seasonal Influenza Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 95. APAC Seasonal Influenza Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 96. APAC Seasonal Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 97. APAC Seasonal Influenza Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Seasonal Influenza Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 99. APAC Seasonal Influenza Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 100. APAC Seasonal Influenza Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Seasonal Influenza Vaccines Sales Quantity by Region (2018-2024) & (K Units)
Table 102. APAC Seasonal Influenza Vaccines Sales Quantity by Region (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 104. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 107. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 111. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 117. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 118. GlaxoSmithKline plc Company Information
Table 119. GlaxoSmithKline plc Description and Overview
Table 120. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 121. GlaxoSmithKline plc Seasonal Influenza Vaccines Product and Services
Table 122. GlaxoSmithKline plc Seasonal Influenza Vaccines SWOT Analysis
Table 123. GlaxoSmithKline plc Recent Developments
Table 124. Sinovac Biotech Ltd Company Information
Table 125. Sinovac Biotech Ltd Description and Overview
Table 126. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 127. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product and Services
Table 128. Sinovac Biotech Ltd Seasonal Influenza Vaccines SWOT Analysis
Table 129. Sinovac Biotech Ltd Recent Developments
Table 130. Changsheng Bio-Technology Company Information
Table 131. Changsheng Bio-Technology Description and Overview
Table 132. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 133. Changsheng Bio-Technology Seasonal Influenza Vaccines Product and Services
Table 134. Changsheng Bio-Technology Seasonal Influenza Vaccines SWOT Analysis
Table 135. Changsheng Bio-Technology Recent Developments
Table 136. Ccbio SA Company Information
Table 137. Ccbio SA Description and Overview
Table 138. Ccbio SA Seasonal Influenza Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 139. Ccbio SA Seasonal Influenza Vaccines Product and Services
Table 140. Ccbio SA Seasonal Influenza Vaccines SWOT Analysis
Table 141. Ccbio SA Recent Developments
Table 142. Aleph Biomedical Company Information
Table 143. Aleph Biomedical Description and Overview
Table 144. Aleph Biomedical Seasonal Influenza Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 145. Aleph Biomedical Seasonal Influenza Vaccines Product and Services
Table 146. Aleph Biomedical Seasonal Influenza Vaccines SWOT Analysis
Table 147. Aleph Biomedical Recent Developments
Table 148. Sanofi Company Information
Table 149. Sanofi Description and Overview
Table 150. Sanofi Seasonal Influenza Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 151. Sanofi Seasonal Influenza Vaccines Product and Services
Table 152. Sanofi Seasonal Influenza Vaccines SWOT Analysis
Table 153. Sanofi Recent Developments
Table 154. Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
Table 155. Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Overview
Table 156. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 157. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product and Services
Table 158. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines SWOT Analysis
Table 159. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
Table 160. Dalian Hissen Bio-pharm Company Information
Table 161. Dalian Hissen Bio-pharm Description and Overview
Table 162. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 163. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product and Services
Table 164. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines SWOT Analysis
Table 165. Dalian Hissen Bio-pharm Recent Developments
Table 166. Abbott Laboratories Company Information
Table 167. Abbott Laboratories Description and Overview
Table 168. Abbott Laboratories Seasonal Influenza Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 169. Abbott Laboratories Seasonal Influenza Vaccines Product and Services
Table 170. Abbott Laboratories Seasonal Influenza Vaccines SWOT Analysis
Table 171. Abbott Laboratories Recent Developments
Table 172. Novartis International AG Company Information
Table 173. Novartis International AG Description and Overview
Table 174. Novartis International AG Seasonal Influenza Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 175. Novartis International AG Seasonal Influenza Vaccines Product and Services
Table 176. Novartis International AG Seasonal Influenza Vaccines SWOT Analysis
Table 177. Novartis International AG Recent Developments
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. Seasonal Influenza Vaccines Distributors List
Table 181. Seasonal Influenza Vaccines Customers List
Table 182. Seasonal Influenza Vaccines Market Trends
Table 183. Seasonal Influenza Vaccines Market Drivers
Table 184. Seasonal Influenza Vaccines Market Challenges
Table 185. Seasonal Influenza Vaccines Market Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Seasonal Influenza Vaccines Product Picture
Figure 2. Global Seasonal Influenza Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Seasonal Influenza Vaccines Market Share by Type in 2022 & 2034
Figure 4. Type A (H1N1) Product Picture
Figure 5. Type A (H3N2) Product Picture
Figure 6. Type B Product Picture
Figure 7. Global Seasonal Influenza Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Seasonal Influenza Vaccines Market Share by Application in 2022 & 2034
Figure 9. Pediatrics
Figure 10. Adolescence
Figure 11. Adults
Figure 12. Elderly
Figure 13. Seasonal Influenza Vaccines Report Years Considered
Figure 14. Global Seasonal Influenza Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Seasonal Influenza Vaccines Revenue 2018-2034 (US$ Million)
Figure 16. Global Seasonal Influenza Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 17. Global Seasonal Influenza Vaccines Sales Quantity 2018-2034 (K Units)
Figure 18. Global Seasonal Influenza Vaccines Sales Quantity Market Share by Region (2018-2024)
Figure 19. Global Seasonal Influenza Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 20. North America Seasonal Influenza Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. North America Seasonal Influenza Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Seasonal Influenza Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. Europe Seasonal Influenza Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Seasonal Influenza Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. China Seasonal Influenza Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 26. APAC Seasonal Influenza Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. APAC Seasonal Influenza Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 29. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Seasonal Influenza Vaccines Sales Quantity in 2022
Figure 31. The Top 10 and Top 5 Players Market Share by Seasonal Influenza Vaccines Revenue in 2022
Figure 32. Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Seasonal Influenza Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 34. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2034)
Figure 35. Global Seasonal Influenza Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 36. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2034)
Figure 37. North America Seasonal Influenza Vaccines Revenue Market Share by Company in 2022
Figure 38. North America Seasonal Influenza Vaccines Sales Quantity Market Share by Company in 2022
Figure 39. North America Seasonal Influenza Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 40. North America Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2034)
Figure 41. North America Seasonal Influenza Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 42. North America Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2034)
Figure 43. North America Seasonal Influenza Vaccines Revenue Share by Country (2018-2034)
Figure 44. North America Seasonal Influenza Vaccines Sales Quantity Share by Country (2018-2034)
Figure 45. U.S. Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Seasonal Influenza Vaccines Sales Quantity Market Share by Company in 2022
Figure 48. Europe Seasonal Influenza Vaccines Revenue Market Share by Company in 2022
Figure 49. Europe Seasonal Influenza Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 50. Europe Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2034)
Figure 51. Europe Seasonal Influenza Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 52. Europe Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2034)
Figure 53. Europe Seasonal Influenza Vaccines Revenue Share by Country (2018-2034)
Figure 54. Europe Seasonal Influenza Vaccines Sales Quantity Share by Country (2018-2034)
Figure 55. Germany Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 56. France Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 57. U.K. Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 58. Italy Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 59. Russia Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 60. China Seasonal Influenza Vaccines Sales Quantity Market Share by Company in 2022
Figure 61. China Seasonal Influenza Vaccines Revenue Market Share by Company in 2022
Figure 62. China Seasonal Influenza Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 63. China Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2034)
Figure 64. China Seasonal Influenza Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 65. China Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2034)
Figure 66. APAC Seasonal Influenza Vaccines Sales Quantity Market Share by Company in 2022
Figure 67. APAC Seasonal Influenza Vaccines Revenue Market Share by Company in 2022
Figure 68. APAC Seasonal Influenza Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 69. APAC Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2034)
Figure 70. APAC Seasonal Influenza Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 71. APAC Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2034)
Figure 72. APAC Seasonal Influenza Vaccines Revenue Share by Region (2018-2034)
Figure 73. APAC Seasonal Influenza Vaccines Sales Quantity Share by Region (2018-2034)
Figure 74. Japan Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 75. South Korea Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 76. China Taiwan Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 78. India Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Quantity Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Quantity Share by Country (2018-2034)
Figure 86. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue Share by Country (2018-2034)
Figure 87. Brazil Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 88. Mexico Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 89. Turkey Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 90. Israel Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 91. GCC Countries Seasonal Influenza Vaccines Revenue (2018-2034) & (US$ Million)
Figure 92. Seasonal Influenza Vaccines Value Chain
Figure 93. Seasonal Influenza Vaccines Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed